Viridian Therapeutics, Inc.\DE - COM (VRDN)

Historical Portfolio Holders from Q4 2020 to Q3 2024

All holders as of June 30, 2024
Q2 2024
Type / Class
Equity / COM
Shares, excl. options Q2 2024
69.5M
Holdings value Q2 2024
$904M
Value change Q2 2024
-$23.3M
Grand Portfolio weight change Q2 2024
0%
Number of holders
135
Number of buys Q2 2024
14
Number of sells Q2 2024
-4
Average buys Q2 2024 %
+0.001%
Average sells Q2 2024 %
-0.001%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 3.51M $79.9M +$23M $22.75 21
2024 Q2 69.5M $904M -$23.3M $13.01 136
2024 Q1 70.9M $1.24B +$174M $17.51 134
2023 Q4 60.1M $1.31B +$204M $21.78 131
2023 Q3 50.2M $770M +$32.7M $15.34 122
2023 Q2 47.1M $1.12B +$92.3M $23.79 131
2023 Q1 43.1M $1.1B +$43.4M $25.44 137
2022 Q4 41.1M $1.2B +$90.9M $29.21 122
2022 Q3 38M $778M +$213M $20.51 103
2022 Q2 28.3M $328M +$27.2M $11.57 84
2022 Q1 24.9M $461M -$3.3M $18.49 73
2021 Q4 23.3M $460M +$113M $19.77 55
2021 Q3 13.6M $224M +$124M $16.45 41
2021 Q2 6M $110M +$18.4M $18.29 24
2021 Q1 5.06M $84.5M +$80.7M $16.71 28
2020 Q4 229K $3.77M +$3.77M $16.46 2